AcuraStem

About:

AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

Website: https://acurastem.com/

Twitter/X: acurastem

Top Investors: National Institutes of Health, Keiretsu Forum, Small Business Innovation Research, California Institute for Regenerative Medicine, U.S. Department of Defense

Description:

AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but they believe tractable, health problems of their time —Amyotrophic Lateral Sclerosis (ALS). AcuraStem harnesses advanced cellular reprogramming and artificial intelligence technologies to transform the standard of care for neurodegenerative diseases through patient-specific treatment.

Total Funding Amount:

$16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Monrovia, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)acurastem.com

Founders:

Justin Ichida, Paul August, Qing Liu, Sam Alworth

Number of Employees:

11-50

Last Funding Date:

2024-09-03

IPO Status:

Private

© 2024 MyAiNote.com